Bing Xia

15.0k total citations · 4 hit papers
268 papers, 10.1k citations indexed

About

Bing Xia is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bing Xia has authored 268 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Molecular Biology, 64 papers in Oncology and 54 papers in Genetics. Recurrent topics in Bing Xia's work include DNA Repair Mechanisms (38 papers), Lung Cancer Treatments and Mutations (33 papers) and Lung Cancer Research Studies (24 papers). Bing Xia is often cited by papers focused on DNA Repair Mechanisms (38 papers), Lung Cancer Treatments and Mutations (33 papers) and Lung Cancer Research Studies (24 papers). Bing Xia collaborates with scholars based in China, United States and Canada. Bing Xia's co-authors include Masayori Inouye, David M. Livingston, Dima Kozakov, Sándor Vajda, Eileen White, Jessie Yanxiang Guo, Hong Cai, Haiping Ke, Kathryn A. Porter and Jianglin Ma and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Bing Xia

255 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2

2006 635 citations Bing Xia, David M. Livingston et al. profile →
RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites

2007 553 citations Bijan Sobhian, Genze Shao et al. Science profile →
Performance and Its Limits in Rigid Body Protein-Protein Docking

2020 446 citations Bing Xia et al. profile →
New additions to the ClusPro server motivated by CAPRI

2016 409 citations Bing Xia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bing Xia China	51	7.1k	2.5k	2.3k	1.4k	1.2k	268	10.1k
Lucia Altucci Italy	62	9.9k 1.4×	1.7k 0.7×	2.1k 0.9×	1.5k 1.0×	1.0k 0.9×	321	14.5k
Alain Sarasin France	61	9.5k 1.3×	1.5k 0.6×	2.9k 1.3×	3.0k 2.1×	842 0.7×	282	12.0k
Shrikant Anant United States	56	5.3k 0.8×	840 0.3×	2.2k 1.0×	1.5k 1.1×	742 0.6×	212	9.3k
Mong‐Hong Lee United States	43	6.7k 0.9×	1.1k 0.4×	3.6k 1.6×	1.7k 1.2×	1.5k 1.3×	103	10.0k
Kristoffer Valerie United States	60	6.4k 0.9×	1.2k 0.5×	3.9k 1.7×	1.6k 1.1×	704 0.6×	164	10.4k
Steven M. Anderson United States	50	4.0k 0.6×	1.3k 0.5×	2.4k 1.1×	1.5k 1.1×	808 0.7×	146	8.7k
Mark J. Arends United Kingdom	51	5.4k 0.8×	920 0.4×	2.5k 1.1×	1.9k 1.4×	1.4k 1.2×	193	9.8k
Jun O. Liu United States	64	8.9k 1.3×	701 0.3×	2.7k 1.2×	1.7k 1.2×	1.4k 1.2×	210	14.2k
Toshiaki Watanabe Japan	48	6.0k 0.9×	1.4k 0.5×	1.5k 0.7×	2.0k 1.4×	788 0.7×	262	10.7k
Douglas E. Brash United States	44	5.7k 0.8×	814 0.3×	2.9k 1.3×	1.6k 1.1×	1.5k 1.3×	96	10.3k

Countries citing papers authored by Bing Xia

Since Specialization

Citations

This map shows the geographic impact of Bing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xia more than expected).

Fields of papers citing papers by Bing Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xia. The network helps show where Bing Xia may publish in the future.

Co-authorship network of co-authors of Bing Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Xia. A scholar is included among the top collaborators of Bing Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Xia. Bing Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Linling, Yasi Xu, Yanyan Zhao, Bing Xia, & Lucheng Zhu. (2025). Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients. Cancer Immunology Immunotherapy. 74(11). 334–334.

Tang, Yi, Mingjiao Sun, Bing Wang, et al.. (2024). Uncovering the connection between Ly6ChiCD103+ myeloid cells and radiation-induced cardiac fibrosis by CyTOF. SHILAP Revista de lepidopterología. 17(3). 101042–101042. 1 indexed citations

Kou, Rong-Wei, Zhiqing Li, Jialin Wang, et al.. (2024). Ganoderic Acid A Mitigates Inflammatory Bowel Disease through Modulation of AhR Activity by Microbial Tryptophan Metabolism. Journal of Agricultural and Food Chemistry. 72(32). 17912–17923. 7 indexed citations

Tan, Ju Le, Bing Xia, Jessica Dobbs, et al.. (2024). EP.12H.02 Amivantamab, An EGFR-MET Bispecific Antibody, with Cetrelimab, An Anti-PD-1 Antibody, In Advanced NSCLC: Phase 1/2 Polydamas. Journal of Thoracic Oncology. 19(10). S657–S658. 1 indexed citations

Huang, Lang, et al.. (2024). Association between personal attenuation rating with types of earplugs and noise exposure levels in a textile factory in China. International Journal of Audiology. 64(11). 1114–1120. 1 indexed citations

Spira, Alexander I., Byoung Chul Cho, Sang-We Kim, et al.. (2024). Amivantamab plus capmatinib in advanced non-small cell lung cancer (NSCLC) harboring MET alterations: Recommended phase 2 combination dose and preliminary dose-escalation results from the phase 1/2 METalmark study.. Journal of Clinical Oncology. 42(16_suppl). 8619–8619. 3 indexed citations

Xia, Bing, Xiaofei Li, Xiaoyan Yang, et al.. (2023). A Novel Silicone Rubber for Situation Awareness. Journal of Physics Conference Series. 2463(1). 12001–12001.

Foo, Tzeh Keong & Bing Xia. (2022). BRCA1-Dependent and Independent Recruitment of PALB2–BRCA2–RAD51 in the DNA Damage Response and Cancer. Cancer Research. 82(18). 3191–3197. 43 indexed citations

Huo, Yanying, Pier Selenica, Amar Mahdi, et al.. (2021). Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development. npj Breast Cancer. 7(1). 45–45. 8 indexed citations

10.

Ferrarotto, Renata, Lori J. Wirth, Jameel Muzaffar, et al.. (2020). 919MO ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut). Annals of Oncology. 31. S663–S663. 17 indexed citations

11.

Park, Pyoung Hwa, Tomomi M. Yamamoto, Hua Li, et al.. (2019). Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations. Molecular Cancer Therapeutics. 19(2). 602–613. 20 indexed citations

12.

Alcivar, Allen L., Jianglin Ma, Tzeh Keong Foo, et al.. (2017). NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress–Induced DPP3–KEAP1 Interaction. Cancer Research. 77(11). 2881–2892. 148 indexed citations

13.

Wang, Hongling, Guoying Zhou, Linjie Luo, et al.. (2015). Serological Screening for Celiac Disease in Adult Chinese Patients With Diarrhea Predominant Irritable Bowel Syndrome. Medicine. 94(42). e1779–e1779. 30 indexed citations

14.

Huo, Yanying, Hong Cai, Irina Teplova, et al.. (2013). Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2 -Associated Hereditary Breast Cancer. Cancer Discovery. 3(8). 894–907. 111 indexed citations

15.

He, Yao, Yujun Chen, Hong Yang, et al.. (2012). Clinical and colonoscopic characteristics of Crohn disease and intestinal tuberculosis. Zhonghua xiaohua neijing zazhi. 29(6). 325–328.

16.

Petrich, Adam M., Violetta V. Leshchenko, Bing Xia, et al.. (2012). Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma. Clinical Cancer Research. 18(9). 2534–2544. 48 indexed citations

17.

Xia, Bing. (2012). Investigation and Analysis of Thymus Wild Resources in China. Northern Horticulture. 2 indexed citations

18.

Wan, Yue‐Meng, et al.. (2011). Treating TNBS-Induced colitis in rats with probiotics. The Turkish Journal of Gastroenterology. 22(5). 486–493. 11 indexed citations

19.

Xia, Bing. (2008). Total RNA extracted from leaf and bulb of Lycoris radiata by an improved method of CsCl density gradient centrifugation. Zhiwu ziyuan yu huanjing. 1 indexed citations

20.

Sobhian, Bijan, Genze Shao, Dana R. Lilli, et al.. (2007). RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites. Science. 316(5828). 1198–1202. 553 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact